Clinical Trial

Deep Parasternal Intercostal Plane Block

Study acronym: DPIP
Completed
View on ClinicalTrials.gov →
Summary
Cardiac surgery is a source of severe post operative pain witch can cause major respiratory complications due to non optimal post operative rehabilitation. Multimodal analgesia provides acceptable pain control , but does not seem sufficient during coughing or mobilization. The use of morphine also exposes patients to side effects (nausea, vomiting, pruritus, respiratory depression, chronic pain, ileus). Bleeding and hemodynamic risks of peridural and spinal aneshesia limits their use. The postoperative efficacy of deep parasternal intercostal plane block has not yet been evaluated sufficiently. The aim of this study is to evaluate the efficacity of TTMPB on the quality of postoperative recovery after cardiac surgery.
Protocol Amendment History 1 change
notable Primary completion moved earlier: 2025-02-12 -> 2022-10-12 2026-05-08
Trial Details
NCT Number NCT06895876
Lead Sponsor Institute Arnault Tzanck, France
Conditions Nerve Block
Enrollment 128 participants
Start Date 2022-08-10
Primary Completion 2022-10-12 (estimated)
Study Completion 2025-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-07